Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date Sort ascending | Purpose |
|---|---|---|---|---|---|
| Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) | PAR-23-053 | NIA | This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations… More | ||
| Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) | RFA-ES-23-011 | NIEHS | This funding opportunity announcement (FOA) is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to… More | ||
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) | PAR-23-076 | NIDA | This Funding Opportunity Announcement (FOA) is to provide support for research Centers that (1) conduct drug abuse and addiction research in any area of NIDAs mission, (2) have outstanding innovative… More | ||
| NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) | PAR-23-049 | NIDA | NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing… More | ||
| Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) | PAR-22-256 | NCI | Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to accelerate the development of evidence-based cancer-related interventions to improve health equity… More | ||
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) | PAR-23-056 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently… More | ||
| HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required) | PAS-22-207 | NIDA | This HEAL FOA provides an opportunity for early career researchers or early career clinicians with foundational backgrounds in addiction to develop expertise in implementation science. Successful… More | ||
| HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required) | PAS-22-206 | NIDA | This HEAL FOA provides an opportunity for early career researchers or early career clinicians with foundational backgrounds in addiction to develop expertise in implementation science. Successful… More | ||
| NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) | PAR-24-120 | NIA | The purpose of the NIA Career Transition Award (CTA) is to facilitate the transition of mentored researchers to tenure-track faculty conducting research that advances the mission of NIA. This three-… More | ||
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) | PAR-23-055 | NCI | This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be… More |